FCNQX | FCNYX | FCNQX / FCNYX | |
Total Expense Ratio | 0.45 | 0.20 | 225% |
Annual Report Gross Expense Ratio | 0.48 | 0.25 | 192% |
Fund Existence | 2 years | 2 years | - |
Gain YTD | 2.134 | 2.262 | 94% |
Front Load | 2% | N/A | - |
Min. Initial Investment | 0 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 7.52B | 7.52B | 100% |
Annual Yield % from dividends | 4.51 | 4.76 | 95% |
Returns for 1 year | 4.73 | 4.99 | 95% |
Returns for 3 years | N/A | N/A | - |
Returns for 5 years | N/A | N/A | - |
Returns for 10 years | N/A | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
ZVGNX | 56.37 | 1.21 | +2.19% |
Zevenbergen Genea Investor | |||
LCGFX | 31.45 | 0.46 | +1.48% |
William Blair Large Cap Growth I | |||
BRSDX | 14.57 | 0.12 | +0.83% |
MFS Blended Research Small Cap Eq A | |||
TADGX | 83.08 | 0.58 | +0.70% |
T. Rowe Price Dividend Growth Advisor | |||
AEMSX | 15.09 | 0.06 | +0.40% |
abrdn Emerging Markets Instl Svc |